` 2216 (Broncus Holding Corp) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

B
2216
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Broncus Holding Corp has significantly outperformed Hang Seng (Hong Kong), delivering a return of +409% compared to the Hang Seng (Hong Kong)'s +50% growth.

Stocks Performance
2216 vs Hang Seng (Hong Kong)

Loading
2216
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com

Performance Gap
2216 vs Hang Seng (Hong Kong)

Loading
2216
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
2216 vs Hang Seng (Hong Kong)

Loading
2216
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Broncus Holding Corp vs Peers

Hang Seng (Hong Kong)
2216
ABT
ISRG
BSX
SYK
Add Stock

Broncus Holding Corp
Glance View

Market Cap
1.4B HKD
Industry
Health Care

Broncus Holding Corp. engages in provision of interventional diagnosis and therapeutics solutions. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2021-09-24. The firm's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.

Intrinsic Value
1.69 HKD
Overvaluation 37%
Intrinsic Value
Price
B
Back to Top